Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 9566251
Volatile anesthetic compositions and methods of use
granted -
US 9566232
Compositions and methods for enhancing the efficacy of contraceptive microbicides
granted -
US 9562230
Transferrin/transferrin receptor-mediated siRNA delivery
granted -
US 9562237
Reduction of TGF beta signaling in myeloid cells in the treatment of cancer
granted -
US 9562223
Methods for reducing intraocular pressure by administering a soluble hyaluronidase glycoprotein (sHASEGP)
granted -
US 9562070
Induction of tumor immunity by variants of folate binding protein
granted -
US 9562056
Imidazopyridines Syk inhibitors
granted -
US 9562073
Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof
granted -
US 9562100
Molecules with extended half-lives, compositions and uses thereof
granted -
US 9562088
Pegylated CD154 peptides and methods of inhibiting CD40 interacations with CD154
granted -
US 9562015
Methods and compositions for enhanced drug delivery to the eye and extended delivery formulations
granted -
US 9562002
STAT3 inhibitor
granted -
US 9561256
LLP2A-bisphosphonate conjugates for osteoporosis treatment
granted -
US 9562020
Dihydroxy aromatic heterocyclic compound
granted -
US 9561229
Emulsion formulations of aprepitant
granted -
US 9561206
Use of heptadecanoic acid (C17:0) to detect risk of and treat hyperferritinemia and metabolic syndrome
granted -
US 9561245
Combination treatments for melanoma
granted -
US 9562039
Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1H)-one derivatives having both β2 adrenergic receptor agonist and M3 muscarinic receptor antagonist activities
granted -
US 9562217
Modalities for the treatment of degenerative diseases of the retina
granted -
US 9555041
Neprilysin inhibitors
granted -
US 9556438
Gene vector
granted -
US 9556200
Tricyclic compound
granted -
US 9556277
Method of treating a TL1A-associated disease or disorder with human antibodies to TL1A
granted -
US 9556237
Antiviral rift valley fever virus peptides and methods of use
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.